{"messages":[{"status":"ok","category":"all"}], "collection":[{"title":"Treatment patterns and outcomes of pediatric rhabdomyosarcoma in a resource-limited setting: A retrospective study from a tertiary hospital in Ethiopia","authors":"Semayneh, S. W.; Liyewu, B. T.; Yohannes, K. G.; Mekonnen, G. A.; Fekadu, A.; Zerihun, S.; Aman, M. A.; Reta, D. T.; Jemil, H. W.","author_corresponding":"Sonia  Worku Semayneh","author_corresponding_institution":"Addis Ababa University School of Medicine","doi":"10.64898\/2026.10.29.26366799","date":"2026-10-31","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"oncology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/10\/31\/2026.10.29.26366799.source.xml","abstract":"Background: Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma. Despite excellent survival in high-income countries, data on treatment and outcomes remain limited in resource-limited settings. The aim of this study was to assess treatment patterns and survival outcomes of pediatric RMS in Ethiopia. Methods: We conducted a retrospective study of newly diagnosed pediatric RMS patients evaluated at Tikur Anbessa Specialized Hospital from January 2021 to September 2025. Data were extracted from medical records, and treatment patterns and survival were assessed using descriptive and Kaplan-Meier analyses. Results: A total of 94 pediatric patients with rhabdomyosarcoma were included. The median age at diagnosis was 4.0 years (IQR: 3.0-6.3 years). Of these patients, 23.4% were classified as low-risk, 61.7% as intermediate-risk, and 14.9% as high-risk. Multimodality treatment was delivered to 59.6% of patients, while 33.0% received chemotherapy alone and 7.4% received no treatment. At diagnosis, curative treatment intent was planned for 83% of patients, but only 71.8% ultimately received it. Treatment received varied by risk group: most (90.0%) low-risk patients got curative treatment, while only 64.3% of intermediate-risk patients got curative treatment intent. No high-risk patients received curative treatment.At a median follow-up of 21.0 months (95% CI: 17.6-24.4 months), median overall survival and event-free survival were 23.0 and 15.0 months, respectively. The 1-year and 2-year overall survival rates were 70% and 42%, respectively, while the corresponding event-free survival rates were 59% and 33%. In multivariable Cox regression, treatment modality (p < 0.001) and total chemotherapy cycles (p =0.001) remained independently associated with overall survival, while risk group was not significant (p =0.14). Conclusion: Pediatric rhabdomyosarcoma in Ethiopia presents with a high rate of high-risk disease. Multimodality therapy and completion of chemotherapy cycles are key determinants of improved survival. These findings highlight the urgent need for early detection, improved access to multimodal treatment, and strategies to reduce treatment abandonment and improve treatment completion rates in resource-limited settings. Larger prospective studies are warranted to validate these findings and guide evidence-based practice.","published":"NA","server":"medRxiv"},{"title":"Machine Learning Based Detection of Chronic Kidney Disease using Full Blood Count from a Ghanaian Hospital Population with an Integrated Web Application","authors":"Akwetey, B. Y.; Lawluvi, E. Y.; Equagoo, T. T.; Kumako, S.; Tsinyo, E. A.; Kumi, R. T.; Mensah, I. R.; Amedume, F. S.; Avuetor, E.; Adikah, C. E.; Mensah, W.; Botuo, J. N.-D.","author_corresponding":"Bismark  Yao Akwetey","author_corresponding_institution":"Ho Technical University","doi":"10.64898\/2026.10.27.26366677","date":"2026-10-31","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/10\/31\/2026.10.27.26366677.source.xml","abstract":"Chronic kidney disease (CKD) is usually silent until advanced, and the tests confirming it are frequently unaffordable in sub-Saharan Africa, whereas the full blood count (FBC) is inexpensive and widely performed. We assessed whether machine learning applied to the FBC can detect CKD, and how far its reported performance depends on where synthetic minority oversampling (SMOTE) is applied. Records of 155 patients at the Ho Technical University Hospital, Ghana, 43 (27.7%) with CKD, yielded ten features: age, cardiovascular disease and eight raw FBC parameters. Eleven algorithms, six resampling strategies and thirteen ensembles were compared under repeated stratified cross-validation. With SMOTE applied before the train-test split, the protocol under which the deployed models were fitted, Random Forest and Extra Trees both reached an accuracy of 83.9%, with sensitivities of 0.893 and 0.857 and areas under the curve (AUC) of 0.925 and 0.939; repeated cross-validation gave an accuracy of 0.809 {+\/-} 0.051 and an AUC of 0.897. With resampling confined to the training folds, the same features gave a held-out accuracy of 61.5% and an AUC of 0.604 in 39 unseen patients. Age was the only variable separating the groups after correction for multiple testing (median 64 versus 47 years, adjusted p = 0.0026). The models are deployed as NephroScan GH (https:\/\/nephroscangh.com), which explains every prediction. The FBC carries a real but moderate signal for CKD, and the 22.4 point gap between the two protocols quantifies how far a single preprocessing decision can move a reported accuracy.","published":"NA","server":"medRxiv"},{"title":"Baseline Physical Activity Guideline Attainment and Mortality Across Cardiovascular-Kidney-Metabolic Syndrome Stages","authors":"Luo, X.; Wang, Y.; Zhou, W.; Yu, F.; Sun, J.; Xiang, K.-F.; Wang, F.; Yuan, Z.; Bao, J.; Zhang, S.; Zheng, Y.; Wu, F.","author_corresponding":"Feng Wu","author_corresponding_institution":"The 72nd Group Army Hospital","doi":"10.64898\/2026.10.28.26366776","date":"2026-10-31","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/10\/31\/2026.10.28.26366776.source.xml","abstract":"Background The 2023 American Heart Association cardiovascular-kidney-metabolic (CKM) staging framework supports risk stratification, but evidence on guideline-level physical activity across stages remains limited. Methods We emulated a target-trial protocol using NHANES 2007-2018 and National Death Index linkage through December 31, 2019. Adults aged 20 to 79 years with CKM stages 1 to 4, estimated glomerular filtration rate of at least 15 mL\/min\/1.73 m2, complete activity data, no cancer history, and eligible follow-up were included. Baseline activity was classified as meeting or not meeting the guideline. Within-stage propensity-score weights were used in weighted Cox models. All-cause and cardiovascular mortality were the primary and secondary outcomes; 5-year risks used weighted survival curves, with competing-risk cumulative incidence also estimated for cardiovascular mortality. Results Among 19,654 participants, 1,190 all-cause deaths occurred during 134,037 person-years. Baseline attainment was associated with lower all-cause mortality overall (HR, 0.774; 95% CI, 0.675-0.888). Stage-specific HRs were 1.030, 0.803, 0.642, and 0.727 for stages 1 to 4, respectively; estimates were nonmonotonic. Five-year risk differences were +0.040, -0.830, -1.790, and -3.840 percentage points; only the stage 4 interval excluded the null. Cardiovascular mortality showed a similar overall cause-specific association (HR, 0.707; 95% CI, 0.547-0.914). Conclusions Observed baseline guideline attainment was associated with mortality in this observational target-trial emulation. The findings are consistent with current physical activity recommendations but do not estimate the effect of an activity-promotion intervention; prospective trials are needed to establish clinical benefit.","published":"NA","server":"medRxiv"},{"title":"Non-contact fingertip video to differentiate dengue haemorrhagic fever in plasma leakage from dengue fever: A prospective proof-of-concept cohort study","authors":"Perera, M. H. M. T. S.; Manamperi, S. T.; Athukorala, S. A. A. J. M.; Wijayawardhana, K. W. S. M.; Wimalasundera, A. R.; Arasaratnam, S.; Prathapa, D. M. J.; Kularathne, Y.","author_corresponding":"M H M Thisara  S Perera","author_corresponding_institution":"National Institute of Infectious Diseases","doi":"10.64898\/2026.10.30.26366674","date":"2026-10-31","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/10\/31\/2026.10.30.26366674.source.xml","abstract":"Most patients with dengue recover without intervention, but a minority develop plasma leakage that threatens the circulation, and differentiating them is the central problem in dengue care. Platelet count is the marker in routine serial use and is itself one of the four defining criteria of dengue haemorrhagic fever (DHF), so thrombocytopenia in dengue fever (DF) can overlap with DHF on the very marker used to distinguish them. We asked whether a non-contact optical signal carries discriminative information beyond platelet count. We conducted a prospective observational cohort study at a national dengue referral centre. All DHF recordings were obtained at or after plasma-leakage onset, so the analysis compares established clinical states rather than pre-leakage risk. Serial non-contact fingertip videos were recorded with contemporaneous clinical and haematological measurements. In a held-out set of 50 recordings (20 DHF, 30 DF), video-derived probability separated the groups with an area under the receiver operating characteristic curve (AUC) of 0.963 (95% CI 0.918-1.000; 0.957 averaged across eight architectures). In the 49 recordings with a platelet count, the video AUC was 0.961 against 0.888 for platelet count (difference 0.074, p = 0.19). In exploratory analyses the video added information to platelet count (likelihood-ratio p < 0.001), showed no significant within-group correlation with platelet count, and retained an AUC of 0.970 against thrombocytopenic DF, where platelet count fell to 0.759. Bedside pulse rate, body temperature and haematocrit did not separate the groups and were unrelated to the video score. A ~30-second fingertip video separated DHF in plasma leakage from DF in this test set, and exploratory analyses suggest it carries information beyond platelet count. These findings are proof of concept from single-centre internal validation, not evidence of pre-leakage prediction; prospective pre-leakage studies and external validation are needed to establish whether the signal can support earlier risk stratification.","published":"NA","server":"medRxiv"},{"title":"Prevalence, Awareness and Correlates of Self-Reported Hypoglycemia Among Adults with Type 2 Diabetes in Northern Jordan: A Cross-Sectional Study","authors":"Khasawneh, A.; Abu Qutaish, A.; Aldeeb, K. M.; Al-Mohammad, T. K.; Al-Mistarehi, A.-H.; Shaheen, S.; Yaseen, R.; Nassar, S. A.; Melhem, M. E.; Okour, H.; Kheirallah, K. A.","author_corresponding":"Khalid  A. Kheirallah","author_corresponding_institution":"Jordan University of Science and Technology Faculty of Medicine","doi":"10.64898\/2026.10.29.26366815","date":"2026-10-31","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"endocrinology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/10\/31\/2026.10.29.26366815.source.xml","abstract":"Hypoglycemia is a frequent and potentially dangerous adverse effect of glucose-lowering therapy in type 2 diabetes mellitus (T2DM), yet data on its prevalence, patient awareness and correlates in Jordan are limited. We conducted a cross-sectional study of 326 adults with T2DM attending family medicine outpatient clinics at a tertiary teaching hospital (King Abdullah University Hospital, KAUH) and a university-affiliated primary healthcare center (JUST PHC) in northern Jordan between 2025 and 2026. Trained interviewers administered a structured questionnaire, and laboratory results were verified from electronic medical records. Hypoglycemia was defined as a glucose level below 70 mg\/dL or symptoms relieved by fast-acting carbohydrate during the preceding six months. Prevalence was estimated with 95% confidence intervals, and associated factors were examined using chi-square tests and multivariable logistic regression. The prevalence of self-reported hypoglycemia was 79.1% (258\/326; 95% CI 74.4-83.2). Although 71.5% of participants knew the symptoms of hypoglycemia, 73.9% were unaware that it can occur without symptoms, 53.6% had never reported an episode to a healthcare provider, only 31.3% had discussed hypoglycemia risk with a physician, and 50.6% never carried sugar or an emergency kit. In the multivariable model, insulin use (adjusted odds ratio [aOR] 3.27, 95% CI 1.75-6.10), sulfonylurea use (aOR 2.14, 1.18-3.87), diabetic nephropathy (aOR 3.76, 1.05-13.48) and attending the primary healthcare center versus the hospital (aOR 2.76, 1.42-5.36) were independently associated with higher odds of hypoglycemia, whereas beta-blocker use was associated with lower odds (aOR 0.52, 0.28-0.95). Self-reported hypoglycemia was highly prevalent among patients with T2DM in northern Jordan, and awareness of asymptomatic hypoglycemia and reporting to providers were limited. Routine structured enquiry about hypoglycemia, patient education that addresses asymptomatic episodes, and review of high-risk therapy, particularly in primary care, are warranted.","published":"NA","server":"medRxiv"}]}